Clinical Trial Update: Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly

View source ↗

Summary

A clinical trial evaluating Ropeginterferon Alfa-2b for polycythemia vera patients without symptomatic splenomegaly is currently recruiting. The sponsor is iOME…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Ropeginterferon alfa-2b (ropeginterferon alfa-2b)

Snippet

Sponsor: iOMEDICO AG | Conditions: Polycythemia Vera | Status: RECRUITING